Molecular Tumor Board at the Center for Personalized Medicine The study objectives are~To ensure a prospective documentation of all patients who are referred to the Molecular Tumor Board in routine clinical care~To prospectively ensure the documentation of MTB patients with an emphasis to clinical outcome parameters progression-free survival (PFS), overall survival (OS) and further response assessments (e.g. peripheral immunmonitoring, imaging parameters)~To prospectively assess patient-reported outcome of MTB patients~To evaluate compliance to MTB suggestions in routine clinical care
Molecular Tumor Board at the Center for Personalized Medicine